7.67
-0.0997(-1.28%)
Currency In USD
| Previous Close | 7.77 |
| Open | 7.78 |
| Day High | 7.84 |
| Day Low | 7.59 |
| 52-Week High | 3,500.42 |
| 52-Week Low | 6.2 |
| Volume | 5,031 |
| Average Volume | 11,498 |
| Market Cap | 4.47M |
| PE | -0.63 |
| EPS | -12.12 |
| Moving Average 50 Days | 7.3 |
| Moving Average 200 Days | 256.01 |
| Change | -0.1 |
If you invested $1000 in Aclarion, Inc. (ACON) since IPO date, it would be worth $0.02 as of September 17, 2025 at a share price of $7.67. Whereas If you bought $1000 worth of Aclarion, Inc. (ACON) shares 2 years ago, it would be worth $0.12 as of September 17, 2025 at a share price of $7.67.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
Aclarion Appoints Greg Gould as Chief Financial Officer
GlobeNewswire Inc.
Sep 03, 2025 10:00 AM GMT
HealthTech CFO with extensive public company experience building organizations for growth and value creation Demonstrated success in raising capital, driving profitability, and scaling operations to $500M revenue while ensuring compliance and strengt
Aclarion Provides Corporate Update Highlighting Scan Volume Growth and Key Upcoming Catalysts
GlobeNewswire Inc.
Aug 05, 2025 10:00 AM GMT
Nociscan YOY scan volume increased 132% from Q2 2024 to Q2 2025 fueled by new physician adoption and insurance company coverage in the UK Company has achieved two consecutive quarters of scan volume growth for the first time and expects continued QOQ
Aclarion, Inc. Announces Adjournment of Annual Meeting of Stockholders
GlobeNewswire Inc.
Jul 07, 2025 8:01 PM GMT
Meeting adjourned to Monday, July 21, 2025 at 9:30 a.m. Mountain Time BROOMFIELD, Colo., July 07, 2025 (GLOBE NEWSWIRE) -- Aclarion, Inc. (“Aclarion” or the “Company”) (Nasdaq: ACON, ACONW), a healthcare technology company that leverages Magnetic R